Manchester Heart Centre,
Manchester Royal Infirmary,
Manchester Heart Centre, Manchester Royal Infirmary
I am a practicing academic cardiologist currently employed at the Senior Lecturer (Associate Professor equivalent) by Manchester University and Manchester Universities NHS hospital trust.
I was previously supported by the Wellcome Trust as a Clinical Intermediate fellow and honorary consultant, and based in the University of Oxford for a decade (2008-19).
I completed a decade in Cambridge University as an MB/PhD student rising ultimately to University Clinical Lecturer in Medicine (1997-2008).
My weekly clinical practice includes inherited cardiac and adult congenital clinics. I provide the PFO closure service for the North West, and have research interests in various aspects of structrual heart disease (TAVR, LAAC, PFOc, PVL), the genetics and genomics of inherited cardiac conditions and development of basic science technologies to enable cardiac repair and cardiac drug testing using stem cell derived platforms. A central focus of this has been development and application of live cell imaging approaches enabled by genetically encoded fluorescent protein technology to cardiomyoctes to directly visualise how they work in health and disease.
I led the Emerging Leader program for the largest cardiac interventional society in the world (SCAI); am a member of the British Cardiac Society Programme Committee, and a member of the Association of Inherited Cardiac Conditions.
Considerations for cardiac catheterization laboratory procedures during the COVID-19 pandemic perspectives from the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship (SCAI ELM) Members and Graduates.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 09, 2020 | Pubmed ID: 32212409
Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?
Circulation 06, 2020 | Pubmed ID: 32282225
Meta-analysis Comparing Transradial Versus Transfemoral Secondary Access in Transcatheter Aortic Valve Implantation.
The American journal of cardiology 09, 2020 | Pubmed ID: 32718554
Homozygous familial hypercholesterolemia with an update on cholesterol management.
Oxford medical case reports Sep, 2020 | Pubmed ID: 32995028
Outcomes of Percutaneous and Surgical Pulmonary Valve Implantation.
Cardiovascular revascularization medicine : including molecular interventions 11, 2021 | Pubmed ID: 33422413
Low Rates of Permanent Pacing Are Observed Following Self-Expanding Transcatheter Aortic Valve Replacement Using an Annular Plane Projection for Deployment.
Circulation. Cardiovascular interventions 01, 2021 | Pubmed ID: 33430606
Sustainable Resumption of Cardiac Catheterization Laboratory Procedures, and the Importance of Testing, During Endemic COVID-19.
Current treatment options in cardiovascular medicine , 2021 | Pubmed ID: 33642850
Myosin Modulation in Hypertrophic Cardiomyopathy and Systolic Heart Failure: Getting Inside the Engine.
Circulation 09, 2021 | Pubmed ID: 34491773
Yu-Fen Chang1,
Wan-Chi Su1,
Chih-Chuan Su1,
Min-Wen Chung1,
Jin Chang2,
You-Yi Li3,
Yi-Ju Kao3,
Wen-Pin Chen3,
Matthew J. Daniels4,5,6
1, LumiSTAR Biotechnology, Inc.,
2, NEXEL Co., Ltd.,
3Institute of Pharmacology, College of Medicine, National Taiwan University,
4Manchester Heart Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust,
5Division of Cardiovascular Sciences, Manchester Academic Health Sciences Centre, University of Manchester,
6Division of Cell Matrix Biology and Regenerative Medicine, University of Manchester
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。